274 Joel Fuhrman, M.D.
Vince. S. E. Nissen, and E. M. TAizcu.
- Arterial remodeling and coro-
nary artery disease: the concept of
"dilated" versus "obstructive" coro-
nary atherosclerosis. J. Am. Coll.
Cardiol. 38 (2): 297-306.
- Elihu, N., S. Anandasbapathy, and
W. H. Frishman. 1998. Chelation
therapy in cardiovascular disease:
elhylenediaminetetraacetic acid, de-
feroxamine, and dexrazoxane. J.
Clin. Pharmacol. 38 (2): 101-05;
Ernst, E. 1997. Chelation therapy
for peripheral arterial occlusive dis-
ease: a systematic review. Circulation
96 (3): 1031-33; Lewin, M. R. 1997.
Chelation therapy for cardiovascular
disease. Review and commentary.
Tex. Heart. Inst. J. 24 (2): 81-89; Can
chelation therapy cure heart dis-
ease? Johns Hopkins Med. Lett. Health
After50. 1999. 10 (4): 8.
- Gould, K. L. 1998. New concepts
and paradigms in cardiovascular
medicine: the noninvasive manage-
ment of coronary artery disease. Am.
J. Med. 104 (6A): 2S-17S; Franklin,
B. A., and J. K. Kahn. 1996. Delayed
progression or regression of coro-
nary atherosclerosis with intensive
risk factor modification: effects of
diet, drugs and exercise. Sports Med.
22 (5): 306-20.
- Kannel, W. B. 1995. Range of serum
cholesterol values in the population
developing coronary artery disease.
Am. J. Cardiol. 76 (9): 69c-77c; Cas-
telli, W. P., K. Anderson, P. W. Wil-
son, and D. Levy. 1992. Lipids and
risk of coronary heart disease: the
Framingham Study. Ann. Epidemiol. 2
(1-2): 23-28.
- Kinosian, B., H. Glick, and G. Gar-
land. 1994. Cholesterol and coro-
nary heart disease: predicting risks
by levels and ratios. Ann. Int. Med.
121 (9): 641-47.
- Miller, E. R„ T. P. Erlinger, D. R.
Young, G. P. Prokopowicz, and L. J.
Appel. 1999. Lifestyle changes that
reduce blood pressure: implementa-
tion in clinical practice. J. Clin. Hy-
pertens. 1: 191-98; Stassen, J., R. Fa-
gard, P. Lijnen, et al. 1989. Body
weight, sodium intake and blood
pressure. ./. Hypertens. 7: S19-S23;
Appel, L. J., T. J. Moore, E. Obar-
zanek, et al., for the DASH Collabora-
tive Research Group. 1997. A clinical
trial of the effects of dietary patterns
on blood pressure. N. Eng. J. Med. 336:
1117-24.
- Whelton, P. K.. L. I. Appel, M. A. Es-
peland, et al. 1998. Sodium reduc-
tion and weight loss in the
treatment of hypertension >n older
persons: a randomized controlled trial
of nonpharmacologic interventions in
the elderly. JAMA 279: 839-46.
- Stafford, R. S., and D. Blumenthal.
- Specialty differences in cardio-
vascular disease prevention practices.
J.Am. Colt. Cardiol. 32 (5): 1238-43.
- Gaster, B., and 1. B. Hirsh. 1998. The
effects of improved glucose control
on complications in type 2 diabetes.
Arch. Intern. Med. 158: 134-^0.
- Stamler, J., O. Vaccaro, J. D. Neaton,
et al. 1993. Diabetes, other risk fac-
tors, and 12-year cardiovascular
mortality for men screened in the
multiple risk factor intervention
trial. Diabetes Care 16: 434-44; Haff-
ner. S. M., S. Lehto, T. Ronnemaa,
et al. 1998. Mortality from coronary
heart disease in subjects with type
2 diabetes and in nondiabetic sub-
jects with and without prior myocar-
dial infarction. N. Eng. J. Med. 339 (4):
229-34; Janka, H. U. 1996. Increased
cardiovascular morbidity and mor-
tality in diabetes mellitus: identifica-
tion of the high risk patient. Diabetes
Res. Clin. Pratt. 30 (supp.): 85-88.
- Crane, M. 1994, Regression of dia-
betic neuropathy with total vegetar-
ian (vegan) diet. J. Nutr. Med. 4: 431.
- Lovejoy, J. C„ M. M. Windhauser,
J. C. Rood, and J. A. De La Bretonne.
- Effects of a controlled high-fat
versus low-fat diet on insulin sensi-
tivity and leptin levels in African-
American and Caucasian women.
Metab. 47: 1520-24.
